Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 1,638.989 million compared to CNY 1,125.977 million a year ago. Operating income was CNY 228.617 million compared to CNY 122.322 million a year ago. Net income was CNY 193.160 million compared to CNY 109.328 million a year ago. Basic earnings per share from continuing operations was CNY 0.06 compared to CNY 0.04 a year ago.